Not Yet Recruiting
A Dose-response Study to Determine the Right Dosage of Sugammadex as a Reversal Agent of Rocuronium in Infants Between 1 and 24 Months Old
NCT07477132
- Conditions
- Curarization, Postoperative Residual, Delayed Emergence from Anesthesia, Pathologic Processes, +2 more
- Locations
-
- Centre Hospitalier universitaire Caen Normandie Caen, France